Skip to main content
9 October 2024
Last updated:
Wednesday 9 October 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Takeovers refocus Sanofi on rare diseases
Read more
Drugs for orphan diseases are no longer rare
Read more
Rare Diseases AbbVie-Shire merger could be a new beginning
Read more
The changing model for rare disease R&D
Read more
Finding a drug for Duchenne muscular dystrophy
Read more
Orphan drug policy: Is the patient being served?
Read more
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form